You are on page 1of 3

EXECUTIVE ORDER

-------

NATIONAL COMMISSION ON THE ORIGINS AND COSTS OF COVID-19

By the authority vested in me as President by the Constitution and the laws of the United States
of America, it is hereby ordered as follows:
Section 1. Establishment. The National Commission on the Origins and Costs of COVID-19
("Commission") is hereby established.
Sec. 2. Membership. (a) The Commission shall be chaired by Senator Thomas B. Cotton and
consist of the following members:
(i) at least three scientists with expertise in virology or infectious diseases;
(ii) at least two economists with expertise in estimating the macroeconomic costs of
exogenous shocks such as COVID-19, including the costs associated with loss of life;
(iii) one or more individuals with expertise in the geopolitics or military strategy of the
People’s Republic of China; and
(iv) one or more individuals from any other area determined by the President to be relevant to
the Commission in fulfilling its duties.
(b) The Chair shall designate from among the Commission members one member to serve as
Vice-Chair.
Sec. 3. Mission and Purpose. (a) The Commission shall investigate the origins of the COVID-
19 pandemic; the economic, political, social, human, and other costs of the pandemic borne by
the United States; and whether the People’s Republic of China or the Chinese Communist Party
have used the pandemic to advance their own economic, geopolitical, military, or territorial
agendas. In conducting its investigation, the Commission shall:
(i) create a comprehensive timeline of events of the COVID-19 pandemic;
(ii) document the facts and circumstances surrounding the origins of the COVID-19
pandemic and any efforts to hide its origins;
(iii) identify actions of governments, actors, organizations, and other entities that may
have played a material role in concealing the dangers presented by COVID-19, including human-
to-human transmission of the virus;
(iv) estimate the economic costs to the United States traceable to COVID-19, accounting
for, among other things, any reduction in economic output, productivity, wages, and real estate
values; any price gouging and hoarding; and the expenditure of significant government funds to
fight the effects of the pandemic;
(v) estimate the human costs to the United States traceable to COVID-19, including loss
of life directly from the virus and indirectly from factors such as pandemic-related delays in
delivering health screenings or medical treatments and the emotional distress associated with
tragic and disruptive events such as the loss of loved ones and the shutdown of critical
institutions such as schools, childcare centers, workplaces, and houses of worship; and
2

(vi) identify actions taken by the People’s Republic of China or the Chinese Communist
Party, or any other organization, individual, or entity acting in cooperation with the People’s
Republic of China or Chinese Communist Party, to use the pandemic to advance economic,
geopolitical, military, or territorial agendas.
(b) The Commission shall recommend actions that the Federal Government may take to
recover any damages as well as all costs estimated under sections 3(a)(iv) and (v) of this order
from any entities identified during the investigation required by section 3(a)(iii) of this order.
Sec. 4. Administration. (a) The Commission shall have a staff, headed by an Executive
Director. The Executive Director shall be appointed by the Chair. In the event of a vacancy, a
new Executive Director shall be appointed or designated by the Chair.
(b) The Department of State shall provide administrative support and funding for the
Commission, to the extent permitted by law.
(c) The heads of all executive departments and agencies, to the extent permitted by law
and consistent with their ongoing responses to COVID-19, shall provide the Commission such
information and cooperation as it may require for purposes of carrying out its mission.
(d) The Commission shall, as necessary, hold public hearings and shall request
information, including relevant documents, from Federal, State, and local officials,
nongovernmental organizations, private entities, scientific institutions, industry and workforce
representatives, and others affected by COVID-19.
(e) The Commission shall consult with distinguished individuals from outside the
Federal Government, who shall not provide their individualized advice to the Commission.
These individuals shall include:
(i) scientists with expertise in virology or infectious diseases;
(ii) economists with expertise in estimating the economic costs of exogenous shocks,
including the costs associated with loss of life and emotional distress within communities; and
(iii) experts on the geopolitical or military strategies, and the economic and territorial
objectives, of the People’s Republic of China and the Chinese Communist Party.
(f) On a periodic basis, but not less than once every 30 days, the Commission shall
provide a detailed update to the Attorney General on the status and scope of its investigation,
with an emphasis on any developments that might affect ongoing or anticipated civil or criminal
enforcement activities by the Department of Justice.
(g) The Commission shall meet as required by the Chair; and, unless extended by the
President, shall terminate within 60 days of accomplishing the objectives set forth in this order
and delivering its final report as specified in subsection (h) of this section.
(h) The Commission shall submit to the President through the Chair:
(i) an interim report within 45 days of the date of this order; and
(ii) a final report for public release within 120 days of the date of this order.
2

Sec. 5. General Provisions. (a) Nothing in this order shall be construed to impair or otherwise
affect:
(i) the authority granted by law to an executive department or agency, or the head
thereof; or
(ii) the functions of the Director of the Office of Management and Budget relating to
budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with applicable law and subject to the
availability of appropriations.
(c) This order is not intended to, and does not, create any right or benefit, substantive or
procedural, enforceable at law or in equity by any party against the United States, its
departments, agencies, or entities, its officers, employees, or agents, or any other person.